Investing Ideas
/
Chinese Pharmaceuticals & Biotech Solid Balance Sheet and Fundamentals

Chinese Pharmaceuticals & Biotech Solid Balance Sheet and Fundamentals

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

Results

0 new

High return on equity, past performance and sound balance sheet.

8 companies

Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
688278 Xiamen Amoytop Biotech	CN¥70.91	4.5%	37.9%	CN¥28.8b	CN¥85.76	PE38.9x	E32.0%	0.6%
600285 Henan Lingrui Pharmaceutical	CN¥22.87	5.5%	38.2%	CN¥12.9b	CN¥30.05	PE19.1x	E16.1%	3.5%
300896 Imeik Technology DevelopmentLtd	CN¥205.18	-2.8%	4.1%	CN¥61.8b	CN¥266.90	PE30.5x	E16.5%	0%
300705 Hunan Jiudian Pharmaceutical	CN¥23.88	-8.9%	-0.8%	CN¥11.8b	CN¥33.10	PE23.2x	E25.5%	1.0%
688578 Shanghai Allist Pharmaceuticals	CN¥61.59	-4.3%	49.5%	CN¥27.7b	CN¥75.00	PE21.4x	E18.4%	0.8%
600436 Zhangzhou Pientzehuang Pharmaceutical	CN¥220.50	-1.3%	-6.4%	CN¥133.0b	CN¥277.61	PE43.2x	E15.9%	1.1%
688506 Sichuan Biokin PharmaceuticalLtd	CN¥196.63	-1.6%	55.5%	CN¥78.8b	CN¥226.42	PE20.7x	E-102.0%	0%
300573 Shenyang Xingqi PharmaceuticalLtd	CN¥77.87	-7.5%	-36.2%	CN¥13.6b	n/a	PE39.2x	n/a	2.6%

Page 1 of 1